All Stories

  1. Melatonin potentiates the antineoplastic effects of venetoclax in acute myeloid leukemia cells

    Article • Hematology Transfusion and Cell Therapy, October 2026, Elsevier

    Dr. Vahid Vahedian

  2. AML-1321: Melatonin Enhances Venetoclax Sensitivity Through Modulation of Apoptotic and Resistance Pathways in Acute Myeloid Leukemia

    Article • Clinical Lymphoma Myeloma & Leukemia, August 2026, Elsevier

    Dr. Vahid Vahedian

  3. Abstract A059: MCHR-1 as an emerging immunotherapy target in ovarian clear cell carcinoma: Opportunities and challenges for translational CAR-T development

    Article • Cancer Research, July 2026, American Association for Cancer Research (AACR)

    Dr. Vahid Vahedian

  4. Targeting “undruggable” cancer proteins: pharmacological challenges and emerging strategies

    Article • Translational Cancer Research, April 2026, AME Publishing Company

    Dr. Vahid Vahedian

  5. CHECKPOINT MOLECULES ON TUMOR CELLS: A PARADIGM SHIFT IN CANCER THERAPY

    Article • Hematology Transfusion and Cell Therapy, March 2026, Elsevier

    Dr. Vahid Vahedian

  6. Tumor-Intrinsic Immune Checkpoints: Emerging Implications for Cancer Progression and Immunotherapy

    Article • Journal of Cancer Therapy, January 2026, Scientific Research Publishing, Inc,

    Dr. Vahid Vahedian

  7. Corrigendum to “Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells” [Europ. J. Pharmacol. 881 (2020) 173282]

    Article • European Journal of Pharmacology, December 2025, Elsevier

    Dr. Vahid Vahedian

  8. Antinociceptive and motor-blocking effects of epidurally administered diphenhydramine at different concentrations in conscious rabbits: a randomized–controlled trial

    Article • Laboratory Animals, August 2025, SAGE Publications

    Dr. Vahid Vahedian

  9. Artemisinin-loaded mesoporous silica nanoparticles/electrospun poly(lactic-co-glycolic acid) composite nanofibers for enhanced anticancer efficiency in breast cancer cells

    Article • Cancer Nanotechnology, November 2024, Springer Science + Business Media

    Dr. Vahid Vahedian

  10. Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view

    Article • Functional & Integrative Genomics, September 2024, Springer Science + Business Media

    Dr. Vahid Vahedian

  11. The molecular crosstalk between innate immunity and DNA damage repair/response: Interactions and effects in cancers

    Article • Pathology - Research and Practice, August 2024, Elsevier

    Dr. Vahid Vahedian

  12. The evaluation of melatonin and EGF interaction on breast cancer metastasis

    Article • Hormone Molecular Biology and Clinical Investigation, July 2024, De Gruyter

    Dr. Vahid Vahedian

  13. The Protective Role of miR-125b in Hepatocellular Carcinoma: Unraveling Tumor-Suppressive Mechanisms

    Article • Current Molecular Medicine, June 2024, Bentham Science Publishers

    Dr. Vahid Vahedian

  14. Interaction between lncRNAs and RNA-binding proteins (RBPs) influences DNA damage response in cancer chemoresistance

    Article • Molecular Biology Reports, February 2024, Springer Science + Business Media

    Dr. Vahid Vahedian

  15. The potential therapeutic effects of Galbanic acid on cancer

    Article • Pathology - Research and Practice, August 2023, Elsevier

    Dr. Vahid Vahedian, Dr. Vahid Vahedian

  16. Xanthomicrol: Effective therapy for cancer treatment

    Article • Toxicology Reports, January 2023, Elsevier

    Dr. Vahid Vahedian, Dr. Vahid Vahedian

  17. An evaluation on potential anti-oxidant and anti-inflammatory effects of Crocin

    Article • Biomedicine & Pharmacotherapy, September 2022, Elsevier

    Dr. Vahid Vahedian, Dr. Vahid Vahedian

  18. Potential tumor marker for hepatocellular carcinoma identification: PI3K and pro-inflammatory cytokines (TGF-β, IL-1, and IL-6)

    Article • Hormone Molecular Biology and Clinical Investigation, June 2022, De Gruyter

    Dr. Vahid Vahedian, Dr. Vahid Vahedian

  19. Vascular mimicry: A potential therapeutic target in breast cancer

    Article • Pathology - Research and Practice, June 2022, Elsevier

    Dr. Vahid Vahedian, Dr. Vahid Vahedian

  20. Dapagliflozin attenuates high glucose‐induced endothelial cell apoptosis and inflammation through AMPK/SIRT1 activation

    Article • Clinical and Experimental Pharmacology and Physiology, April 2022, Wiley

    Dr. Vahid Vahedian

  21. The role of SOX family in cancer stem cell maintenance: With a focus on SOX2

    Article • Pathology - Research and Practice, March 2022, Elsevier

    Dr. Vahid Vahedian, Dr. Vahid Vahedian

  22. Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line

    Article • Breast Cancer, November 2021, Springer Science + Business Media

    Dr. Vahid Vahedian

  23. Potential Therapeutic Effects of Melatonin Mediate via miRNAs in Cancer

    Article • Biochemical Genetics, June 2021, Springer Science + Business Media

    Dr. Vahid Vahedian

  24. The potential therapeutic effects of melatonin on breast cancer: An invasion and metastasis inhibitor

    Article • Pathology - Research and Practice, October 2020, Elsevier

    Dr. Vahid Vahedian

  25. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.

    Article • European Journal of Pharmacology, August 2020, Elsevier

    Dr. Vahid Vahedian

  26. Targeting cancer stem cells by melatonin: Effective therapy for cancer treatment

    Article • Pathology - Research and Practice, May 2020, Elsevier

    Dr. Vahid Vahedian

  27. Human Amnion Membrane Proteins Prevent Doxorubicin-Induced Oxidative Stress Injury and Apoptosis in Rat H9c2 Cardiomyocytes

    Article • Cardiovascular Toxicology, February 2020, Springer Science + Business Media

    Dr. Vahid Vahedian

  28. The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways

    Article • Breast Cancer, February 2020, Springer Science + Business Media

    Dr. Vahid Vahedian

  29. A glimpse into molecular mechanisms of embryonic stem cells pluripotency: Current status and future perspective

    Article • Journal of Cellular Physiology, February 2020, Wiley

    Dr. Vahid Vahedian, Dr. Vahid Vahedian

  30. Anti-inflammatory activity of emu oil-based nanofibrous scaffold through downregulation of IL-1, IL-6, and TNF-α pro-inflammatory cytokines

    Article • Hormone Molecular Biology and Clinical Investigation, January 2020, De Gruyter

    Nazila Fathi Maroufi, Dr. Vahid Vahedian

  31. Therapeutic potentials of Apatinib in cancer treatment: Possible mechanisms and clinical relevance

    Article • Life Sciences, January 2020, Elsevier

    Dr. Vahid Vahedian, Dr. Vahid Vahedian

  32. Sensitization of MDA-MBA231 breast cancer cell to docetaxel by myricetin loaded into biocompatible lipid nanoparticles via sub-G1 cell cycle arrest mechanism

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, August 2019, Springer Science + Business Media

    Dr. Vahid Vahedian

  33. Nrf2 activation and down-regulation of HMGB1 and MyD88 expression by amnion membrane extracts in response to the hypoxia-induced injury in cardiac H9c2 cells

    Article • Biomedicine & Pharmacotherapy, January 2019, Elsevier

    Dr. Vahid Vahedian

  34. Antioxidative effects of proteglycans of embryonic genesis in streptozotocin-induced diabetic rats

    Article • Research and Reports in Biochemistry, January 2013, Taylor & Francis

    Kevorkian Guevork, Mikhayil Aghajanov, Levon Mkrtchyan, Dr. Vahid Vahedian, Dr. Vahid Vahedian